Integra Lifesciences Holdings (IART) Other Non-Current Liabilities (2009 - 2026)

Integra Lifesciences Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $195.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 21.87% year-over-year to $195.6 million; the TTM figure through Mar 2026 stood at $195.6 million (up 21.87% YoY), while the FY2025 annual figure was $204.3 million, up 39.69% from the prior year.
• Other Non-Current Liabilities came in at $195.6 million for Q1 2026 at Integra Lifesciences Holdings, down from $204.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $253.2 million in Q2 2025 to a low of $25.0 million in Q4 2022.
• A 5-year average of $150.9 million and a median of $153.3 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities plunged 79.21% in 2022 and surged 699.76% in 2023, its largest moves.
• Integra Lifesciences Holdings' Other Non-Current Liabilities stood at $25.0 million in 2022, then soared by 699.76% to $199.9 million in 2023, then retreated by 26.86% to $146.2 million in 2024, then soared by 39.69% to $204.3 million in 2025, then dropped by 4.27% to $195.6 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $195.6 million, $204.3 million, and $233.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison